Kalbų laboratorija - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 49,895 | 130,509 | 128,330 | 79,822 | 51,414 | 35,542 | 23,565 | 18,568 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 1,695 | 16,819 | 28,095 | 4,411 | -11,576 | -4,231 | 1,676 | 1,165 |
| Equity | 4,490 | 20,979 | 44,475 | 38,536 | 16,610 | 12,380 | 14,056 | 6,986 |
| Liabilities | 877 | 4,277 | 2,391 | 1,359 | 1,394 | 403 | 173 | 166 |
| Non-current assets | 786 | 437 | 828 | 478 | 773 | 365 | 147 | 74 |
| Current assets | 4,561 | 24,307 | 45,432 | 39,417 | 17,231 | 12,418 | 14,082 | 7,078 |
| Total assets | 5,347 | 24,744 | 46,260 | 39,895 | 18,004 | 12,783 | 14,229 | 7,152 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 2,011 | 685 | 2,095 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +8809.8% | +161.6% | -1.7% | -37.8% | -35.6% | -30.9% | -33.7% | -21.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 31.7% | 68.0% | 60.7% | 11.1% | -64.3% | -33.1% | 11.8% | 16.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 37.8% | 80.2% | 63.2% | 11.4% | -69.7% | -34.2% | 11.9% | 16.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.4% | 12.9% | 21.9% | 5.5% | -22.5% | -11.9% | 7.1% | 6.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.2 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 15,756 | 34,802 | 38,499 | 23,362 | 15,048 | 15,796 | 11,783 | 9,284 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Kalbų laboratorija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-18 | 2026-03-09 | 0.90 |
| 2024-11-18 | 2024-12-02 | 0.35 |
| 2024-10-24 | 2024-11-04 | 0.35 |
| 2024-08-19 | 2024-08-20 | 243.33 |
| 2022-04-19 | 2022-04-20 | 0.40 |
Kalbų laboratorija - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-17 | 2025-05-19 | 119.42 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Kalbu laboratorija, UAB (code 304726033) is a Private Limited Liability Company operating in other education n.e.c. In 2025, the company generated revenue of €18.6K and net profit of €1.2K, giving a profit margin of 6.3%. Revenue declined by 21.2% year on year and by 47.8% over two years, but profitability remained positive after the loss recorded in 2023. The company moved from a net loss of €4.2K in 2023 to a profit of €1.7K in 2024 and €1.2K in 2025, showing a smaller but stable earnings base in the latest year. Balance sheet figures for 2025 were compact: total assets stood at €7.2K, equity at €7.0K and liabilities at €166, indicating very low leverage and an equity ratio of 97.7%. Key efficiency metrics were also supportive, with asset turnover at 2.60x, return on equity at 16.7% and return on assets at 16.3%. Revenue per employee was €9.3K and profit per employee was €582, suggesting modest scale but positive operating efficiency.